Evidence map›Paper›PMID 35528661›Full record

ArticleRSC advances2019

A comprehensive study of eriocitrin metabolism

Luya Li, Xue Feng, Yuting Chen, Shenghao Li, Yupeng Sun, Lantong Zhang

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Luya LiDepartment of Pharmaceutical Analysis, School of Pharmacy, Hebei Medical University Shijiazhuang 050017 P. R. China zhanglantong@263.net +86-311-86266419 +86-311-86266419.ORCID https://orcid.org/0000-0003-1544-4600
Xue FengDepartment of Pharmaceutical Analysis, School of Pharmacy, Hebei Medical University Shijiazhuang 050017 P. R. China zhanglantong@263.net +86-311-86266419 +86-311-86266419.
Yuting ChenDepartment of Pharmaceutical Analysis, School of Pharmacy, Hebei Medical University Shijiazhuang 050017 P. R. China zhanglantong@263.net +86-311-86266419 +86-311-86266419.
Shenghao LiDepartment of Pathobiology and Immunology, Hebei University of Chinese Medicine Shijiazhuang 050000 P. R. China.
Yupeng SunDepartment of Pharmaceutical Analysis, School of Pharmacy, Hebei Medical University Shijiazhuang 050017 P. R. China zhanglantong@263.net +86-311-86266419 +86-311-86266419.
Lantong ZhangDepartment of Pharmaceutical Analysis, School of Pharmacy, Hebei Medical University Shijiazhuang 050017 P. R. China zhanglantong@263.net +86-311-86266419 +86-311-86266419.
Hebei Medical University · CNShijiazhuang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Eriocitrin, a main flavonoid in lemons, possesses strong antioxidant, lipid-lowering and anticancer activities and has long been used in food, beverages and wine. However, its metabolism

Identifiers

PMID35528661
PMCPMC9069865
OpenAlexW2966920843

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.